The precise role of MLH1 in mammalian MMR is not clear. Using a genetically-matched HCT116 cell system the applicants recently demonstrated that cells lacking the MLH1 DNA mismatch repair (MMR) gene exhibited a """"""""damage-tolerant"""""""" phenotype and were unable to arrest at the G2/M cell cycle checkpoint following exposure to 5-fluoro-2'- deoxyuridine (FdUrd). They hypothesize that MLH-1 mediated MMR participates in the detection of FdUrd-induced DNA damage and that MLH1 expression is specifically required for both damage detection and G2/M checkpoint arrest responses. Arrest at G2/M may be the result of generation of DNA double strand breaks as a by-product to MMR activity, or through an as yet unidentified role of MLH1. The following Specific Aims will test this hypothesis:
Specific Aim 1 : To determine if MLH1 plans an unique role in relating G2/M cell cycle arrest, or if a defective G2/M arrest is common to cells with deficiencies in other MMR genes after FdUrd exposure. (Years 0-3).
Specific Aim 2 : To demonstrate that MLH1 plans a role in MMR activity and the regulation of G2/M cell cycle arrest after FdUrd treatment using cells from MLH1 knockout mice. (Years 0-3).
Specific Aim 3 : To determine if differences in G2/M arrest after FdUrd exposure between cells expressing or lacking MLH1, PMS2, or MSH2 are associated with MMR-mediated creating of DNA double-strand breaks (DSBs). (Years 2-5).
Specific Aim 4 : To determine if the DNA-directed cytotoxicity observed in cells expressing MLH1 following FdUrd treatment is due to the inhibition of thymidylate synthetase (TS) or to direct incorporation of FdUrd into DNA. (Years 1-5). 5-Fluorouracil (FUra), remains a standard drug used for colon cancer and many combined treatment modalities have been designed to increase its """"""""DNA-level"""""""" cytotoxicity. Their preliminary data strongly suggest that such DNA-targeted cytotoxicity may be contra-indicated when treating the tumors of patients with HNPCC. A better understanding of the mechanisms of FdUrd-mediated DNA lesion detection by MMR may allow them to (a) elucidate a major DNA repair mechanism within the cell for maintaining genomic stability following pool imbalances of FdUrd incorporation in DNA; (b) determine whether MMR in general, or MLH1 specifically, controls G2/M arrest responses after FdUrd treatment; and (c) eventually determine the signaling pathways which connect MMR detection of DNA damage to apoptotic cell death, since a significant apoptotic response was associated with MMR-specific killing after FdUrd treatment.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA083196-04
Application #
6497576
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Program Officer
Forry, Suzanne L
Project Start
1999-04-01
Project End
2004-01-31
Budget Start
2002-02-01
Budget End
2004-01-31
Support Year
4
Fiscal Year
2002
Total Cost
$211,905
Indirect Cost
Name
Case Western Reserve University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Galindo, C L; McCormick, J F; Bubb, V J et al. (2011) A long AAAG repeat allele in the 5' UTR of the ERR-? gene is correlated with breast cancer predisposition and drives promoter activity in MCF-7 breast cancer cells. Breast Cancer Res Treat 130:41-8
Galindo, Cristi L; McIver, Lauren J; Tae, Hongseok et al. (2011) Sporadic breast cancer patients' germline DNA exhibit an AT-rich microsatellite signature. Genes Chromosomes Cancer 50:275-83
Li, Long Shan; Morales, Julio C; Veigl, Martina et al. (2009) DNA mismatch repair (MMR)-dependent 5-fluorouracil cytotoxicity and the potential for new therapeutic targets. Br J Pharmacol 158:679-92
Wagner, Mark W; Li, Long Shan; Morales, Julio C et al. (2008) Role of c-Abl kinase in DNA mismatch repair-dependent G2 cell cycle checkpoint arrest responses. J Biol Chem 283:21382-93
Criswell, Tracy; Leskov, Konstantin; Miyamoto, Shigeki et al. (2003) Transcription factors activated in mammalian cells after clinically relevant doses of ionizing radiation. Oncogene 22:5813-27
Meyers, Mark; Hwang, Arlene; Wagner, Mark W et al. (2003) A role for DNA mismatch repair in sensing and responding to fluoropyrimidine damage. Oncogene 22:7376-88
Yan, T; Schupp, J E; Hwang, H S et al. (2001) Loss of DNA mismatch repair imparts defective cdc2 signaling and G(2) arrest responses without altering survival after ionizing radiation. Cancer Res 61:8290-7
Miyamoto, S; Huang, T T; Wuerzberger-Davis, S et al. (2000) Cellular and molecular responses to topoisomerase I poisons. Exploiting synergy for improved radiotherapy. Ann N Y Acad Sci 922:274-92